tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PHVS Stock Latest News

Pharvaris reports safety and efficacy data of deucrictibant
The FlyPharvaris reports safety and efficacy data of deucrictibant
7d ago
PHVS
Pharvaris price target raised to $55 from $46 at JMP Securities
PremiumThe Fly
Pharvaris price target raised to $55 from $46 at JMP Securities
1M ago
PHVS
Pharvaris Sets 2025 Strategic Priorities in HAE and AAE Treatments
PremiumCompany Announcements
Pharvaris Sets 2025 Strategic Priorities in HAE and AAE Treatments
2M ago
6K
PHVS
Pharvaris price target lowered to $46 from $50 at JMP Securities
PremiumThe Fly
Pharvaris price target lowered to $46 from $50 at JMP Securities
3M ago
PHVS
Pharvaris Reports Q3 2024 Progress and Financials
PremiumCompany Announcements
Pharvaris Reports Q3 2024 Progress and Financials
3M ago
PHVS
Pharvaris Advances in HAE Treatment with Strong Financials
PremiumCompany AnnouncementsPharvaris Advances in HAE Treatment with Strong Financials
4M ago
6K
PHVS
Pharvaris reports Q3 EPS (EUR 0.77) vs (EUR 0.58) last year
Premium
The Fly
Pharvaris reports Q3 EPS (EUR 0.77) vs (EUR 0.58) last year
4M ago
PHVS
Pharvaris announces data from posters to be presented at 2024 ACAAI
Premium
The Fly
Pharvaris announces data from posters to be presented at 2024 ACAAI
5M ago
PHVS
Oppenheimer healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Oppenheimer healthcare analysts hold an analyst/industry conference call
5M ago
PHVS
KalVista initiated with a Buy at JonesResearch
PremiumThe Fly
KalVista initiated with a Buy at JonesResearch
5M ago
KALV
PHVS
Pharvaris CBO Resigns, Team Absorbs Duties
PremiumCompany Announcements
Pharvaris CBO Resigns, Team Absorbs Duties
6M ago
6K
PHVS
Pharvaris Refines License Terms with BRAIN Biotech
PremiumCompany Announcements
Pharvaris Refines License Terms with BRAIN Biotech
6M ago
6K
PHVS
Pharvaris initiated with a Buy at JonesResearch
PremiumThe FlyPharvaris initiated with a Buy at JonesResearch
6M ago
PHVS
Oppenheimer healthcare analysts hold an analyst/industry conference call
Premium
The Fly
Oppenheimer healthcare analysts hold an analyst/industry conference call
6M ago
PHVS
Pharvaris price target raised to $42 from $38 at Oppenheimer
Premium
The Fly
Pharvaris price target raised to $42 from $38 at Oppenheimer
6M ago
PHVS
Pharvaris Reveals Positive HAE Drug Data
PremiumCompany Announcements
Pharvaris Reveals Positive HAE Drug Data
6M ago
6K
PHVS
Pharvaris’ deucrictibant shows safety and tolerability in Phase 2 HAE study
PremiumThe Fly
Pharvaris’ deucrictibant shows safety and tolerability in Phase 2 HAE study
6M ago
PHVS
Pharvaris provides business update, expands deucrictibant development program
PremiumThe Fly
Pharvaris provides business update, expands deucrictibant development program
6M ago
PHVS
Pharvaris Advances HAE Treatment Trials
PremiumCompany Announcements
Pharvaris Advances HAE Treatment Trials
7M ago
6K
PHVS
Wedbush reveals three potential buyout targets for Biogen
PremiumThe FlyWedbush reveals three potential buyout targets for Biogen
8M ago
BIIB
EWTX
3 Best Stocks to Buy Now, 7/4/2024, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 7/4/2024, According to Top Analysts
8M ago
VET
LEGN
Pharvaris price target raised to $38 from $36 at Oppenheimer
Premium
The Fly
Pharvaris price target raised to $38 from $36 at Oppenheimer
8M ago
PHVS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >